PROM1 and cancer: As shown in Figure 2C, stem cell surface marker CD133 and stemness proteins OCT3/4, SOX2 expression levels were increased in A549/PTX CD133+ cells than in CD133- cells, indicating that the cancer stem cell-marker and stemness protein levels are significantly higher in A549/PTX CD133+ cells than in CD133- cells.